foxo4-dri senolytic peptide 2024 study Frontiers | FOXO4-DRI regulates endothelial
Description
J., Bleakman, D., Zimmerman, D
FOXO4-DRI, designed to disrupt the FOXO4-p53 interaction, was tested on senescent TM3 Leydig cells
Thus, in studies by Khan et al
As interest in these peptides continues to grow, concerns about fake, underdosed, or poorly handled products have also increased
